Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：105 Table Number：125
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Blood Plasma Derivatives market in this environment. In terms of revenue, this research report indicated that the global Blood Plasma Derivatives market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Blood Plasma Derivatives industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Grifols aims at producing XX K Units Blood Plasma Derivatives in 2020, with XX % production to take place in global market, SK Plasma accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Blood Plasma Derivatives Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Blood Plasma Derivatives Market? Grifols SK Plasma Fusion Health Care Biotest Green Cross Baxter International LFB Octapharma CSL Shire ... Major Type of Blood Plasma Derivatives Covered in XYZResearch report: lbumin Factor VIII Factor IX Immunoglobulin Hyperimmune Globulin Others Application Segments Covered in XYZResearch Market Hemophilia Hypogammaglobinemia Immunodeficiency Diseases von Willebrands Disease For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Blood Plasma Derivatives Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 lbumin -Product Introduction and Major Manufacturers 1.1.2 Factor VIII -Product Introduction and Major Manufacturers 1.1.3 Factor IX -Product Introduction and Major Manufacturers 1.1.4 Immunoglobulin -Product Introduction and Major Manufacturers 1.1.5 Hyperimmune Globulin -Product Introduction and Major Manufacturers 1.1.6 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Blood Plasma Derivatives Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Blood Plasma Derivatives Market 3.1.1 Top Companies leading Blood Plasma Derivatives Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Blood Plasma Derivatives Market 3.2.1 Top Companies leading Blood Plasma Derivatives Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Blood Plasma Derivatives Market 3.3.1 Top Companies leading Blood Plasma Derivatives Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Blood Plasma Derivatives Market 3.4.1 Top Companies leading Blood Plasma Derivatives Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Blood Plasma Derivatives Market 3.5.1 Top Companies leading Blood Plasma Derivatives Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Blood Plasma Derivatives Market 3.6.1 Top Companies leading Blood Plasma Derivatives Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Blood Plasma Derivatives Market 3.7.1 Top Companies leading Blood Plasma Derivatives Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Blood Plasma Derivatives Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Blood Plasma Derivatives Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Blood Plasma Derivatives Sales and Growth Rate (2021-2027) 5.2 Global Blood Plasma Derivatives Sales Value and Growth Rate (2021-2027) 6 Blood Plasma Derivatives Competitive Analysis 6.1 Grifols 6.1.1 Grifols Company Profiles 6.1.2 Grifols Product Introduction 6.1.3 Grifols Blood Plasma Derivatives Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 SK Plasma 6.2.1 SK Plasma Company Profiles 6.2.2 SK Plasma Product Introduction 6.2.3 SK Plasma Blood Plasma Derivatives Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Fusion Health Care 6.3.1 Fusion Health Care Company Profiles 6.3.2 Fusion Health Care Product Introduction 6.3.3 Fusion Health Care Blood Plasma Derivatives Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Biotest 6.4.1 Biotest Company Profiles 6.4.2 Biotest Product Introduction 6.4.3 Biotest Blood Plasma Derivatives Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Green Cross 6.5.1 Green Cross Company Profiles 6.5.2 Green Cross Product Introduction 6.5.3 Green Cross Blood Plasma Derivatives Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Baxter International 6.6.1 Baxter International Company Profiles 6.6.2 Baxter International Product Introduction 6.6.3 Baxter International Blood Plasma Derivatives Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 LFB 6.7.1 LFB Company Profiles 6.7.2 LFB Product Introduction 6.7.3 LFB Blood Plasma Derivatives Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Octapharma 6.8.1 Octapharma Company Profiles 6.8.2 Octapharma Product Introduction 6.8.3 Octapharma Blood Plasma Derivatives Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 CSL 6.9.1 CSL Company Profiles 6.9.2 CSL Product Introduction 6.9.3 CSL Blood Plasma Derivatives Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 Shire 6.10.1 Shire Company Profiles 6.10.2 Shire Product Introduction 6.10.3 Shire Blood Plasma Derivatives Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Blood Plasma Derivatives Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Blood Plasma Derivatives Sales (K Unit) by Type (2026-2027) Figure Global Blood Plasma Derivatives Sales (K Unit) and Growth Rate (2026-2027) Figure Global Blood Plasma Derivatives Sales Market Share (%) by Type (2019 -2020) Table Global Blood Plasma Derivatives Sales Value (Million USD) by Type (2026-2027) Figure Global Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Blood Plasma Derivatives Sales Value Market Share (%) by Type (2019-2020) Table Global Blood Plasma Derivatives Sales (K Unit) by Application (2026-2027) Table China Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table China Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table China Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure China Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table China Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table China Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table China Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure China Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table EU Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table EU Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table EU Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure EU Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table EU Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table EU Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure EU Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table USA Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table USA Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table USA Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure USA Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table USA Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table USA Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure USA Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table Japan Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table Japan Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table Japan Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table Japan Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table Japan Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure Japan Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table India Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table India Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table India Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure India Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table India Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table India Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table India Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure India Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table Southeast Asia Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table Southeast Asia Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table Southeast Asia Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure Southeast Asia Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Table South America Blood Plasma Derivatives Sales (K Unit) of Major Company (2016-2021) Table South America Blood Plasma Derivatives Sales Market Share of Major Company (2016-2021) Table South America Blood Plasma Derivatives Sales Value (Million USD) of Major Company (2016-2021) Figure South America Blood Plasma Derivatives Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Blood Plasma Derivatives Sales Value Share of Major Company (2016-2021) Table South America Blood Plasma Derivatives Price (USD/Unit), by Type (2019-2020) Table South America Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure South America Blood Plasma Derivatives Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Blood Plasma Derivatives Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Blood Plasma Derivatives Figure Cost Structure of Blood Plasma Derivatives in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Blood Plasma Derivatives Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Blood Plasma Derivatives Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Grifols Profiles Table Grifols Blood Plasma Derivatives Product Introduction Table Grifols Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Grifols SWOT Analysis Table SK Plasma Profiles Table SK Plasma Blood Plasma Derivatives Product Introduction Table SK Plasma Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure SK Plasma SWOT Analysis Table Fusion Health Care Profiles Table Fusion Health Care Blood Plasma Derivatives Product Introduction Table Fusion Health Care Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Fusion Health Care SWOT Analysis Table Biotest Profiles Table Biotest Blood Plasma Derivatives Product Introduction Table Biotest Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Biotest SWOT Analysis Table Green Cross Profiles Table Green Cross Blood Plasma Derivatives Product Introduction Table Green Cross Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Green Cross SWOT Analysis Table Baxter International Profiles Table Baxter International Blood Plasma Derivatives Product Introduction Table Baxter International Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Baxter International SWOT Analysis Table LFB Profiles Table LFB Blood Plasma Derivatives Product Introduction Table LFB Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure LFB SWOT Analysis Table Octapharma Profiles Table Octapharma Blood Plasma Derivatives Product Introduction Table Octapharma Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Octapharma SWOT Analysis Table CSL Profiles Table CSL Blood Plasma Derivatives Product Introduction Table CSL Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure CSL SWOT Analysis Table Shire Profiles Table Shire Blood Plasma Derivatives Product Introduction Table Shire Blood Plasma Derivatives Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
